Clinical Trial Update: The Effects of Diquafosol Tetrasodium Ophthalmic Solution, 2% in Subjects With Dry Eye Disease (P08637) [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating diquafosol tetrasodium ophthalmic solution 2% for dry eye disease has completed. The update provides the status of the study (NCT008316…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease

Drugs mentioned

• Diquafosol Tetrasodium Ophthalmic Solution, 2% (diquafosol tetrasodium ophthalmic solution)

Snippet

Sponsor: Merck Sharp & Dohme LLC | Conditions: Dry Eye Disease | Phase 3 | Status: COMPLETED